BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12435043)

  • 1. Clinical experience with adenovirus in cancer therapy.
    Palmer DH; Mautner V; Kerr DJ
    Curr Opin Mol Ther; 2002 Oct; 4(5):423-34. PubMed ID: 12435043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial design for adenoviral gene therapy products.
    Shirakawa T
    Drug News Perspect; 2009 Apr; 22(3):140-5. PubMed ID: 19440556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adenovirus vectors and their clinical application in gene therapy].
    Adám E; Nász I
    Orv Hetil; 2001 Sep; 142(38):2061-70. PubMed ID: 11697063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of PEGylated adenovirus vector with targeting ligand.
    Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
    Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).
    Bauerschmitz GJ; Barker SD; Hemminki A
    Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment.
    Hunt KK; Vorburger SA
    Science; 2002 Jul; 297(5580):415-6. PubMed ID: 12130788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectively replicating oncolytic adenoviruses as cancer therapeutics.
    Yu DC; Working P; Ando D
    Curr Opin Mol Ther; 2002 Oct; 4(5):435-43. PubMed ID: 12435044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vectors--how to use them in cancer gene therapy?
    Majhen D; Ambriović-Ristov A
    Virus Res; 2006 Aug; 119(2):121-33. PubMed ID: 16533542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral vectors: systemic delivery and tumor targeting.
    Green NK; Seymour LW
    Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenoviral p53 gene therapy for human lung cancer].
    Fujiwara T; Tanaka N
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of adenoviral vectors for gene therapy of cancer.
    Zhang WW
    Cancer Gene Ther; 1999; 6(2):113-38. PubMed ID: 10195879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
    Kirn D
    Gene Ther; 2001 Jan; 8(2):89-98. PubMed ID: 11313778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy and molecular therapeutic for head and neck cancer].
    Tanaka H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2046-51. PubMed ID: 16352927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.
    Egami T; Ohuchida K; Yasui T; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
    Cancer Sci; 2009 Oct; 100(10):1902-7. PubMed ID: 19604247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy progress and prospects: adenoviral vectors.
    St George JA
    Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.